Does use of a biologic agent increase the incidence of postoperative infection in surgery for rheumatoid arthritis after total joint arthroplasty?
Abstract Objectives. The goal of the study was to examine the influence of biological agents on postoperative infections such as surgical site infection (SSI) and late infection in patients with rheumatoid arthritis after total joint arthroplasty at our hospital between January 2006 and December 201...
Gespeichert in:
| Veröffentlicht in: | Modern rheumatology 2014-05, Vol.24 (3), p.430-433 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 433 |
|---|---|
| container_issue | 3 |
| container_start_page | 430 |
| container_title | Modern rheumatology |
| container_volume | 24 |
| creator | Kubota, Ayako Sekiguchi, Masayuki Nakamura, Takashi Miyazaki, Yoshiyasu Suguro, Toru |
| description | Abstract
Objectives. The goal of the study was to examine the influence of biological agents on postoperative infections such as surgical site infection (SSI) and late infection in patients with rheumatoid arthritis after total joint arthroplasty at our hospital between January 2006 and December 2011.
Methods. The patients were divided into groups with (Bio group, 267 joints) and without (Non-Bio group, 300 joints) treatment with biological agents. We examined the incidence of postoperative infection in Bio group and Non-Bio group. Multivariate logistic regression analysis was performed to identify the risk factor of postoperative infection.
Results. The incidences of superficial and deep SSI were 0.37% and 1.0%, respectively, in the Bio group, and 0.67% and 0%, respectively, in the Non-Bio group, with no significant difference between the two groups. The incidences of late infection were 1.0% and 0% in the Bio and Non-Bio groups, respectively, again with no significant difference between the groups. Multivariate logistic regression analysis revealed the following values for the surgery of the foot and ankle region [P = 0.001, odds ratio (OR) = 19.27; 95% confidence interval (CI) 4.67-79.45].
The use of biological agents was not a risk factor for postoperative infection.
Conclusions. These results suggest that the use of biological agents does not significantly increase the incidences of SSI and late infection after orthopedic surgery in patients with rheumatoid arthritis after total joint arthroplasty. |
| doi_str_mv | 10.3109/14397595.2013.844387 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1523407155</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3351629031</sourcerecordid><originalsourceid>FETCH-LOGICAL-c536t-72f0b52624a776f10490d2e5a603ed32d258996258c9413a667715b457f59963</originalsourceid><addsrcrecordid>eNp9kU1v1DAQhiMEoh_wDxCyxIXLLo4_4vhChQoFpEpceo9mk_HGqyRexg5o_wa_GKfbRcChF3s888w7tt-ieFXytSy5fVcqaY22ei14Kde1UrI2T4rzJb0yFbdPT3FmzoqLGHecS21r-7w4E0powbk4L359DBjZHJEFx4BtfBjC1rcMtjgl5qeWEHIx9bgcfIdTe4_uQ0xhjwTJ_1hKDtvkw5QjFmfaIh2YC8Sox3mEFHzHgFJPPvnIwCUklkKCge2Cz3Pua2E_QEyHqxfFMwdDxJcP-2Vxd_Pp7vrL6vbb56_XH25XrZZVWhnh-EaLSigwpnIlV5Z3AjVUXGInRSd0bW2V19aqUkJVGVPqjdLG6ZyXl8Xbo-yewvcZY2pGH1scBpgwzLEptZCK5xad0Tf_obsw05QvlynFrRE1XwTVkWopxEjomj35EejQlLxZLGtOljWLZc3Rstz2-kF83ozY_Wk6eZSBqyOQfznQCD8DDV2T4DAEcgTZlbjIPzri_T8KPcKQ-hYI_3rIYwK_AUeaucE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1540972806</pqid></control><display><type>article</type><title>Does use of a biologic agent increase the incidence of postoperative infection in surgery for rheumatoid arthritis after total joint arthroplasty?</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Kubota, Ayako ; Sekiguchi, Masayuki ; Nakamura, Takashi ; Miyazaki, Yoshiyasu ; Suguro, Toru</creator><creatorcontrib>Kubota, Ayako ; Sekiguchi, Masayuki ; Nakamura, Takashi ; Miyazaki, Yoshiyasu ; Suguro, Toru</creatorcontrib><description>Abstract
Objectives. The goal of the study was to examine the influence of biological agents on postoperative infections such as surgical site infection (SSI) and late infection in patients with rheumatoid arthritis after total joint arthroplasty at our hospital between January 2006 and December 2011.
Methods. The patients were divided into groups with (Bio group, 267 joints) and without (Non-Bio group, 300 joints) treatment with biological agents. We examined the incidence of postoperative infection in Bio group and Non-Bio group. Multivariate logistic regression analysis was performed to identify the risk factor of postoperative infection.
Results. The incidences of superficial and deep SSI were 0.37% and 1.0%, respectively, in the Bio group, and 0.67% and 0%, respectively, in the Non-Bio group, with no significant difference between the two groups. The incidences of late infection were 1.0% and 0% in the Bio and Non-Bio groups, respectively, again with no significant difference between the groups. Multivariate logistic regression analysis revealed the following values for the surgery of the foot and ankle region [P = 0.001, odds ratio (OR) = 19.27; 95% confidence interval (CI) 4.67-79.45].
The use of biological agents was not a risk factor for postoperative infection.
Conclusions. These results suggest that the use of biological agents does not significantly increase the incidences of SSI and late infection after orthopedic surgery in patients with rheumatoid arthritis after total joint arthroplasty.</description><identifier>ISSN: 1439-7595</identifier><identifier>EISSN: 1439-7609</identifier><identifier>DOI: 10.3109/14397595.2013.844387</identifier><identifier>PMID: 24252002</identifier><language>eng</language><publisher>United States: Informa Healthcare</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Antirheumatic Agents - adverse effects ; Antirheumatic Agents - therapeutic use ; Arthritis, Rheumatoid - drug therapy ; Arthritis, Rheumatoid - surgery ; Arthroplasty, Replacement - adverse effects ; Biological Products - adverse effects ; Biological Products - therapeutic use ; Biologics ; Female ; Humans ; Incidence ; Joint surgery ; Male ; Medical treatment ; Middle Aged ; Orthopedic surgery ; Postoperative infection ; Regression analysis ; Rheumatoid arthritis ; Rheumatology ; Risk factors ; Surgical Wound Infection - epidemiology ; Surgical Wound Infection - etiology ; Treatment Outcome</subject><ispartof>Modern rheumatology, 2014-05, Vol.24 (3), p.430-433</ispartof><rights>2014 Japan College of Rheumatology 2014</rights><rights>Copyright Informa Healthcare May 2014</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c536t-72f0b52624a776f10490d2e5a603ed32d258996258c9413a667715b457f59963</citedby><cites>FETCH-LOGICAL-c536t-72f0b52624a776f10490d2e5a603ed32d258996258c9413a667715b457f59963</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24252002$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kubota, Ayako</creatorcontrib><creatorcontrib>Sekiguchi, Masayuki</creatorcontrib><creatorcontrib>Nakamura, Takashi</creatorcontrib><creatorcontrib>Miyazaki, Yoshiyasu</creatorcontrib><creatorcontrib>Suguro, Toru</creatorcontrib><title>Does use of a biologic agent increase the incidence of postoperative infection in surgery for rheumatoid arthritis after total joint arthroplasty?</title><title>Modern rheumatology</title><addtitle>Mod Rheumatol</addtitle><description>Abstract
Objectives. The goal of the study was to examine the influence of biological agents on postoperative infections such as surgical site infection (SSI) and late infection in patients with rheumatoid arthritis after total joint arthroplasty at our hospital between January 2006 and December 2011.
Methods. The patients were divided into groups with (Bio group, 267 joints) and without (Non-Bio group, 300 joints) treatment with biological agents. We examined the incidence of postoperative infection in Bio group and Non-Bio group. Multivariate logistic regression analysis was performed to identify the risk factor of postoperative infection.
Results. The incidences of superficial and deep SSI were 0.37% and 1.0%, respectively, in the Bio group, and 0.67% and 0%, respectively, in the Non-Bio group, with no significant difference between the two groups. The incidences of late infection were 1.0% and 0% in the Bio and Non-Bio groups, respectively, again with no significant difference between the groups. Multivariate logistic regression analysis revealed the following values for the surgery of the foot and ankle region [P = 0.001, odds ratio (OR) = 19.27; 95% confidence interval (CI) 4.67-79.45].
The use of biological agents was not a risk factor for postoperative infection.
Conclusions. These results suggest that the use of biological agents does not significantly increase the incidences of SSI and late infection after orthopedic surgery in patients with rheumatoid arthritis after total joint arthroplasty.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antirheumatic Agents - adverse effects</subject><subject>Antirheumatic Agents - therapeutic use</subject><subject>Arthritis, Rheumatoid - drug therapy</subject><subject>Arthritis, Rheumatoid - surgery</subject><subject>Arthroplasty, Replacement - adverse effects</subject><subject>Biological Products - adverse effects</subject><subject>Biological Products - therapeutic use</subject><subject>Biologics</subject><subject>Female</subject><subject>Humans</subject><subject>Incidence</subject><subject>Joint surgery</subject><subject>Male</subject><subject>Medical treatment</subject><subject>Middle Aged</subject><subject>Orthopedic surgery</subject><subject>Postoperative infection</subject><subject>Regression analysis</subject><subject>Rheumatoid arthritis</subject><subject>Rheumatology</subject><subject>Risk factors</subject><subject>Surgical Wound Infection - epidemiology</subject><subject>Surgical Wound Infection - etiology</subject><subject>Treatment Outcome</subject><issn>1439-7595</issn><issn>1439-7609</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU1v1DAQhiMEoh_wDxCyxIXLLo4_4vhChQoFpEpceo9mk_HGqyRexg5o_wa_GKfbRcChF3s888w7tt-ieFXytSy5fVcqaY22ei14Kde1UrI2T4rzJb0yFbdPT3FmzoqLGHecS21r-7w4E0powbk4L359DBjZHJEFx4BtfBjC1rcMtjgl5qeWEHIx9bgcfIdTe4_uQ0xhjwTJ_1hKDtvkw5QjFmfaIh2YC8Sox3mEFHzHgFJPPvnIwCUklkKCge2Cz3Pua2E_QEyHqxfFMwdDxJcP-2Vxd_Pp7vrL6vbb56_XH25XrZZVWhnh-EaLSigwpnIlV5Z3AjVUXGInRSd0bW2V19aqUkJVGVPqjdLG6ZyXl8Xbo-yewvcZY2pGH1scBpgwzLEptZCK5xad0Tf_obsw05QvlynFrRE1XwTVkWopxEjomj35EejQlLxZLGtOljWLZc3Rstz2-kF83ozY_Wk6eZSBqyOQfznQCD8DDV2T4DAEcgTZlbjIPzri_T8KPcKQ-hYI_3rIYwK_AUeaucE</recordid><startdate>20140501</startdate><enddate>20140501</enddate><creator>Kubota, Ayako</creator><creator>Sekiguchi, Masayuki</creator><creator>Nakamura, Takashi</creator><creator>Miyazaki, Yoshiyasu</creator><creator>Suguro, Toru</creator><general>Informa Healthcare</general><general>Taylor & Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>20140501</creationdate><title>Does use of a biologic agent increase the incidence of postoperative infection in surgery for rheumatoid arthritis after total joint arthroplasty?</title><author>Kubota, Ayako ; Sekiguchi, Masayuki ; Nakamura, Takashi ; Miyazaki, Yoshiyasu ; Suguro, Toru</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c536t-72f0b52624a776f10490d2e5a603ed32d258996258c9413a667715b457f59963</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antirheumatic Agents - adverse effects</topic><topic>Antirheumatic Agents - therapeutic use</topic><topic>Arthritis, Rheumatoid - drug therapy</topic><topic>Arthritis, Rheumatoid - surgery</topic><topic>Arthroplasty, Replacement - adverse effects</topic><topic>Biological Products - adverse effects</topic><topic>Biological Products - therapeutic use</topic><topic>Biologics</topic><topic>Female</topic><topic>Humans</topic><topic>Incidence</topic><topic>Joint surgery</topic><topic>Male</topic><topic>Medical treatment</topic><topic>Middle Aged</topic><topic>Orthopedic surgery</topic><topic>Postoperative infection</topic><topic>Regression analysis</topic><topic>Rheumatoid arthritis</topic><topic>Rheumatology</topic><topic>Risk factors</topic><topic>Surgical Wound Infection - epidemiology</topic><topic>Surgical Wound Infection - etiology</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kubota, Ayako</creatorcontrib><creatorcontrib>Sekiguchi, Masayuki</creatorcontrib><creatorcontrib>Nakamura, Takashi</creatorcontrib><creatorcontrib>Miyazaki, Yoshiyasu</creatorcontrib><creatorcontrib>Suguro, Toru</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Modern rheumatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kubota, Ayako</au><au>Sekiguchi, Masayuki</au><au>Nakamura, Takashi</au><au>Miyazaki, Yoshiyasu</au><au>Suguro, Toru</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Does use of a biologic agent increase the incidence of postoperative infection in surgery for rheumatoid arthritis after total joint arthroplasty?</atitle><jtitle>Modern rheumatology</jtitle><addtitle>Mod Rheumatol</addtitle><date>2014-05-01</date><risdate>2014</risdate><volume>24</volume><issue>3</issue><spage>430</spage><epage>433</epage><pages>430-433</pages><issn>1439-7595</issn><eissn>1439-7609</eissn><abstract>Abstract
Objectives. The goal of the study was to examine the influence of biological agents on postoperative infections such as surgical site infection (SSI) and late infection in patients with rheumatoid arthritis after total joint arthroplasty at our hospital between January 2006 and December 2011.
Methods. The patients were divided into groups with (Bio group, 267 joints) and without (Non-Bio group, 300 joints) treatment with biological agents. We examined the incidence of postoperative infection in Bio group and Non-Bio group. Multivariate logistic regression analysis was performed to identify the risk factor of postoperative infection.
Results. The incidences of superficial and deep SSI were 0.37% and 1.0%, respectively, in the Bio group, and 0.67% and 0%, respectively, in the Non-Bio group, with no significant difference between the two groups. The incidences of late infection were 1.0% and 0% in the Bio and Non-Bio groups, respectively, again with no significant difference between the groups. Multivariate logistic regression analysis revealed the following values for the surgery of the foot and ankle region [P = 0.001, odds ratio (OR) = 19.27; 95% confidence interval (CI) 4.67-79.45].
The use of biological agents was not a risk factor for postoperative infection.
Conclusions. These results suggest that the use of biological agents does not significantly increase the incidences of SSI and late infection after orthopedic surgery in patients with rheumatoid arthritis after total joint arthroplasty.</abstract><cop>United States</cop><pub>Informa Healthcare</pub><pmid>24252002</pmid><doi>10.3109/14397595.2013.844387</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1439-7595 |
| ispartof | Modern rheumatology, 2014-05, Vol.24 (3), p.430-433 |
| issn | 1439-7595 1439-7609 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1523407155 |
| source | MEDLINE; Oxford University Press Journals All Titles (1996-Current) |
| subjects | Adult Aged Aged, 80 and over Antirheumatic Agents - adverse effects Antirheumatic Agents - therapeutic use Arthritis, Rheumatoid - drug therapy Arthritis, Rheumatoid - surgery Arthroplasty, Replacement - adverse effects Biological Products - adverse effects Biological Products - therapeutic use Biologics Female Humans Incidence Joint surgery Male Medical treatment Middle Aged Orthopedic surgery Postoperative infection Regression analysis Rheumatoid arthritis Rheumatology Risk factors Surgical Wound Infection - epidemiology Surgical Wound Infection - etiology Treatment Outcome |
| title | Does use of a biologic agent increase the incidence of postoperative infection in surgery for rheumatoid arthritis after total joint arthroplasty? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T09%3A01%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Does%20use%20of%20a%20biologic%20agent%20increase%20the%20incidence%20of%20postoperative%20infection%20in%20surgery%20for%20rheumatoid%20arthritis%20after%20total%20joint%20arthroplasty?&rft.jtitle=Modern%20rheumatology&rft.au=Kubota,%20Ayako&rft.date=2014-05-01&rft.volume=24&rft.issue=3&rft.spage=430&rft.epage=433&rft.pages=430-433&rft.issn=1439-7595&rft.eissn=1439-7609&rft_id=info:doi/10.3109/14397595.2013.844387&rft_dat=%3Cproquest_cross%3E3351629031%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1540972806&rft_id=info:pmid/24252002&rfr_iscdi=true |